| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |